Clinical trials: Intermittent Catheterization
Female Intermittent Urethral Catheterization
Evaluation of a New Female Urinary Intermittent Catheter
A prospective, multi-centre, interventional study. All subjects will use the study device for two weeks and the angulated handle available with the device must be used by each subject at least 10 times.
- Trial name
- NCT04304599
- Testing
- LoFric Elle
- Where
- 4 sites in Spain, Sweden
- Volunteers
- 20 people
- Sponsor
- Wellspect HealthCare
Intermittent Urethral Catheterization
Clinical Study Evaluating the Safety of a New Catheter for Urinary Intermittent Catheterization in Self Catheterized Patients
The clinical study evaluates the safety of a new catheter for Urinary Intermittent Catheterisation in self catheterized patients
- Trial name
- NCT02911051
- Testing
- Actreen Hydrolite Cath
- Where
- France
- Volunteers
- 22 people
- Sponsor
- BBraun Medical SAS
Urinary Function
Investigate Bladder and Prostate During Emptying With Intermittent Catheter
Explorative study investigating the urinary bladder and prostate during intermittent catheterization in healthy male adults by use of MR-scanning.
- Trial name
- NCT05560594
- Testing
- Coloplast SpeediCath CH12 standard male intermittent catheter
- Where
- Denmark
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- Coloplast A/S
Urinary Incontinence
An Exploratory Investigation of the Effects of Single Use vs. Reuse Catheters in Intermittent Catheterization
The overall aim of the investigation is to investigate the effect of repeated reuse of intermittent urinary catheters and to observe the impact of switch from single use to multiple reuse catheters.
- Trial name
- NCT05626686
- Testing
- CLINY catheter
- Where
- Denmark
- Volunteers
- 40 people
- Sponsor
- Coloplast A/S
Bladder Outlet Obstruction, Multiple Sclerosis
GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology
Male self catherterisng observational study.
- Conditions
- Bladder Outlet Obstruction, Multiple Sclerosis, Cauda Equina Syndrome, Enlarged Prostate With Lower Urinary Tract Symptoms
- Trial name
- NCT05470751
- Testing
- Intermittent self-catheterisation
- Where
- 16 sites in United States, France and 1 more
- Volunteers
- 72 people
- Sponsor
- ConvaTec Inc.
Intermittent Catheterization
CP382 - Intermittent Catheter (IC) PRO Panel Plan
The aim is to create an electronic patient reported outcome (e-PRO) based registry, specifically for subjects using an intermittent catheter as their primary bladder emptying method.
- Trial name
- 382 PRO Panel (NCT07475468)
- Testing
- No Intervention: Observational Cohort
- Volunteers
- 1,000 people
- Sponsor
- Coloplast A/S
Neurogenic Detrusor Overactivity
Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity
The objective of the study was to evaluate the efficacy, safety, tolerability and pharmacokinetics of mirabegron after multiple-dose administration in the pediatric population.
- Trial name
- Crocodile (NCT02751931)
- Testing
- Mirabegron
- Where
- 32 sites in Australia, Belgium and 17 more
- Volunteers
- 91 people
- Sponsor
- Astellas Pharma Europe B.V.
Urinary Bladder, Overactive
Voiding Efficiency, a Predictor of Clean Intermittent Catheterization (CIC)
This study is a retrospective chart review of patients treated with onabotulinumtoxinA (BOTOX®) for idiopathic overactive bladder (OAB) and will determine voiding efficiency (VE) cutoff ratios that predict post-procedure urinary…
- Trial name
- NCT03043287
- Testing
- onabotulinumtoxinA
- Where
- 3 sites in United States
- Volunteers
- 420 people
- Sponsor
- Allergan
Intermittent Urethral Catheterization
Evaluation of a New Catheter Coating Process for Urinary Catheters Used for Intermittent Catheterization.
This is a prospective, double-blinded, randomized, multi-centre, cross-over study. All subjects will use both the study device (test catheter) and the comparator (control catheter) for one week each.
- Trial name
- NCT03684941
- Testing
- Treatment Period One, Treatment Period Two
- Where
- 8 sites in Sweden
- Volunteers
- 60 people
- Sponsor
- Dentsply International
Intermittent Urethral Catheterization
Safety and Performance of a New Coating for Urinary Intermittent Catheters
The aim of the study is to evaluate safety and performance of a new catheter coating,compared to the current SpeediCath coating.
- Trial name
- NCT01800903
- Testing
- ZN-D catheter, ZN-C catheter, SpeediCath catheter
- Where
- Denmark
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Coloplast A/S